Similar Articles
541 Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”
542 Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis
543 Laparoscopic vs open liver re-resection for cirrhotic patients with post-hepatectomy hepatocellular carcinoma recurrence: A comparative study
544 Providing higher value care for hepatocellular carcinoma rather than diagnosis: What can current radiologists do?
545 Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
546 Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
547 Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography
548 Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
549 Digital single-operator cholangioscopy for biliary stricture after cadaveric liver transplantation
550 Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA